<DOC>
	<DOCNO>NCT02706236</DOCNO>
	<brief_summary>The study purpose characterize effect pancreatic enzyme supplementation chronic pancreatitis type pain .</brief_summary>
	<brief_title>Trial Pancreatic Enzyme Supplements ( Pancrelipase ) Treating Pain Patients With Chronic Pancreatitis</brief_title>
	<detailed_description>Study Type : Interventional , randomize , double-blind , placebo-controlled , crossover design , efficacy study Intervention arm : Pancreatic enzyme replacement ( Pancrelipase ) meal snack daily , 4 week . Placebo arm : Lactose placebo tablet meal snack , 4 week . Washout Phase : Weeks 4 6 , cessation placebo Pancrelipase use . Crossover Phase : Weeks 6 10 , initial placebo arm receive Pancrelipase , Pancrelipase arm receive placebo Surveys - Izbicki score PANQOLI assessment occur Week 0 , 4 , 6 , 10 . Narcotic non-narcotic usage also note interval . Patient also report tobacco alcohol use .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Diagnosis chronic pancreatitis base chronic pancreatitistype pain &gt; 6 month lead impaired quality life AND least 1 follow ( 27 ) : Confirmed diagnosis hereditary pancreatitis ( PRSS1 gene mutation ) History recurrent acute pancreatitis ( &gt; 1 documented episode characteristic abdominal pain associate diagnostic imaging and/or elevate serum amylase lipase &gt; 3 time upper limit normal ) . Pancreatic calcification CT scan At least 2 follow : Endoscopic Ultrasound ( EUS ) = &gt; 4 criterion chronic pancreatitis ( hyperechoic focus , strand , duct , lobulation , irregular duct margin , visible side branch , calcification , cyst , ductal dilatation ) ( 28 ) Ductal ( change side branch morphology ) parenchymal ( loss T1 signal intensity ) abnormalities secretin enhance Magnetic resonance cholangiopancreatography ( MRCP ) Abnormal endoscopic pancreatic secretory function test ( HCO3 &lt; = 75mmol/L 30 45 minute &lt; = 80mmol/L 1 hour Subjects capable informed consent Pregnancy Lactation Active acute pancreatitis episode acute pancreatitis within 2 month presentation evaluation Pancreatic cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>